$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams

$ams Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000074482521000054 Filed on May 13, 2021

Income Statement

Concept	2021 Q1	2020 Q4	2020 Q1
Revenue	$4.364M	$4.608M	$4.568M
YoY Change	-4.47%	-3.72%	-14.15%
Cost Of Revenue	$2.930M	$3.581M	$3.174M
YoY Change	-7.69%	7.06%	-6.21%
Gross Profit	$1.434M	$1.027M	$1.394M
YoY Change	2.87%	-28.73%	-28.03%
Gross Profit Margin	32.86%	22.29%	30.52%
Selling, General & Admin	$1.084M	$1.052M	$1.211M
YoY Change	-10.49%	22.47%	14.79%
% of Gross Profit	75.59%	102.43%	86.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.231M	$1.761M	$1.676M
YoY Change	-26.55%	7.44%	-12.25%
% of Gross Profit	85.84%	171.47%	120.23%
Operating Expenses	$1.084M	$1.052M	$1.211M
YoY Change	-10.49%	22.47%	14.79%
Operating Profit	$90.00K	-$25.00K	-$99.00K
YoY Change	-190.91%	-104.3%	-119.22%
Interest Expense	$260.0K	-$251.0K	$282.0K
YoY Change	-7.8%	-16.89%	-23.16%
% of Operating Profit	288.89%
Other Income/Expense, Net
YoY Change
Pretax Income	$93.00K	-$8.540M	-$96.00K
YoY Change	-196.88%	-3150.0%	-118.5%
Income Tax	$6.000K	-$1.545M	-$28.00K
% Of Pretax Income	6.45%
Net Earnings	$29.00K	-$6.231M	-$135.0K
YoY Change	-121.48%	-3328.5%	-150.0%
Net Earnings / Revenue	0.66%	-135.22%	-2.96%
Basic Earnings Per Share	$0.00		-$0.02
Diluted Earnings Per Share	$0.00	-$951.6K	-$0.02
COMMON SHARES
Basic Shares Outstanding	6.254M	5.761M shares	6.126M shares
Diluted Shares Outstanding	6.322M		6.153M shares

Balance Sheet

Concept	2021 Q1	2020 Q4	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.895M	$3.961M	$2.673M
YoY Change	83.13%	177.19%	30.45%
Cash & Equivalents	$4.895M	$3.961M	$3.023M
Short-Term Investments
Other Short-Term Assets	$1.482M	$2.314M	$1.712M
YoY Change	-13.43%	2.84%	24.87%
Inventory
Prepaid Expenses
Receivables	$4.792M	$4.303M	$5.988M
Other Receivables	$280.0K	$272.0K	$265.0K
Total Short-Term Assets	$11.45M	$10.85M	$10.64M
YoY Change	7.62%	1.01%	10.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$30.35M	$30.42M	$42.14M
YoY Change	-27.99%	-26.67%	-6.49%
Goodwill	$1.265M	$1.265M
YoY Change
Intangibles	$78.00K	$78.00K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$78.00K	$137.0K	$411.0K
YoY Change	-81.02%	-69.89%	-51.87%
Total Long-Term Assets	$32.60M	$32.80M	$42.55M
YoY Change	-23.39%	-23.79%	-9.88%
TOTAL ASSETS
Total Short-Term Assets	$11.45M	$10.85M	$10.64M
Total Long-Term Assets	$32.60M	$32.80M	$42.55M
Total Assets	$44.05M	$43.65M	$53.19M
YoY Change	-17.19%	-18.83%	-6.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$885.0K	$683.0K	$851.0K
YoY Change	4.0%	22.62%	90.81%
Accrued Expenses	$3.454M	$2.755M	$2.221M
YoY Change	55.52%	51.62%	19.99%
Deferred Revenue
YoY Change
Short-Term Debt	$355.0K	$471.0K	$0.00
YoY Change		-0.84%
Long-Term Debt Due	$782.0K	$1.157M	$4.662M
YoY Change	-83.23%	-24.18%	128.08%
Total Short-Term Liabilities	$7.286M	$12.38M	$7.829M
YoY Change	-6.94%	50.72%	-10.9%
LONG-TERM LIABILITIES
Long-Term Debt	$11.82M	$3.440M	$10.42M
YoY Change	13.41%	76.05%	260.25%
Other Long-Term Liabilities	$695.0K	$791.0K	$981.0K
YoY Change	-29.15%	-28.93%	-29.58%
Total Long-Term Liabilities	$11.82M	$3.440M	$11.40M
YoY Change	3.66%	76.05%	294.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.286M	$12.38M	$7.829M
Total Long-Term Liabilities	$11.82M	$3.440M	$11.40M
Total Liabilities	$19.11M	$15.82M	$27.24M
YoY Change	-29.85%	55.59%	133.19%
SHAREHOLDERS EQUITY
Retained Earnings	$1.526M	$1.497M
YoY Change		-82.5%
Common Stock	$17.88M	$17.78M
YoY Change		1.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.41M	$19.27M	$25.95M
YoY Change
Total Liabilities & Shareholders Equity	$44.05M	$43.65M	$53.19M
YoY Change	-17.19%	-18.83%	-6.45%

Cashflow Statement

Concept	2021 Q1	2020 Q4	2020 Q1
OPERATING ACTIVITIES
Net Income	$29.00K	-$6.231M	-$135.0K
YoY Change	-121.48%	-3328.5%	-150.0%
Depreciation, Depletion And Amortization	$1.231M	$1.761M	$1.676M
YoY Change	-26.55%	7.44%	-12.25%
Cash From Operating Activities	$2.783M	$1.688M	$3.389M
YoY Change	-17.88%	-12.08%	47.35%
INVESTING ACTIVITIES
Capital Expenditures	$1.065M	-$127.0K	$195.0K
YoY Change	446.15%	25.74%	-28.31%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$1.065M	-$127.0K	-$195.0K
YoY Change	446.15%	-51.34%	74.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$276.0K		$554.0K
YoY Change	-50.18%		7.36%
Cash From Financing Activities	-$1.030M	-1.219M	-$1.950M
YoY Change	-47.18%	-20.17%	23.34%
NET CHANGE
Cash From Operating Activities	$2.783M	1.688M	$3.389M
Cash From Investing Activities	-$1.065M	-127.0K	-$195.0K
Cash From Financing Activities	-$1.030M	-1.219M	-$1.950M
Net Change In Cash	$688.0K	342.0K	$1.244M
YoY Change	-44.69%	159.09%	104.94%
FREE CASH FLOW
Cash From Operating Activities	$2.783M	$1.688M	$3.389M
Capital Expenditures	$1.065M	-$127.0K	$195.0K
Free Cash Flow	$1.718M	$1.815M	$3.194M
YoY Change	-46.21%	-10.19%	57.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000744825
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5801000	shares
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-08789
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	American Shared Hospital Services
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-2918118
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	Two Embarcadero Center,
CY2021Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 410
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco,
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94111
CY2021Q1	dei	City Area Code CityAreaCode	415
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	788-5300
CY2021Q1	dei	Security12b Title Security12bTitle	American Shared Hospital Services Common Stock, No Par Value
CY2021Q1	dei	Trading Symbol TradingSymbol	AMS
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4895000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3961000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	118000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	364000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4792000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4303000	USD
CY2021Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	280000	USD
CY2020Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	272000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1364000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1950000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	11449000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	10850000	USD
CY2021Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	70718000	USD
CY2020Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	75657000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	394000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	330000	USD
CY2021Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1178000	USD
CY2020Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	170000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	72290000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	76157000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	41944000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	45739000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30346000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30418000	USD
CY2021Q1	ams	Other Land Noncurrent OtherLandNoncurrent	19000	USD
CY2020Q4	ams	Other Land Noncurrent OtherLandNoncurrent	19000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	1265000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	1265000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	812000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	886000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	78000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	78000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	78000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	137000	USD
CY2021Q1	us-gaap	Assets Assets	44047000	USD
CY2020Q4	us-gaap	Assets Assets	43653000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	885000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	683000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	432000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	405000	USD
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2712000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1574000	USD
CY2021Q1	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	1214000	USD
CY2020Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	1270000	USD
CY2021Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	399000	USD
CY2020Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	373000	USD
CY2021Q1	ams	Working Capital Payment Due WorkingCapitalPaymentDue	197000	USD
CY2020Q4	ams	Working Capital Payment Due WorkingCapitalPaymentDue	197000	USD
CY2021Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	355000	USD
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	471000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	310000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	305000	USD
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	782000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1157000	USD
CY2021Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	0	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	5945000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	7286000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12380000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	502000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	581000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11820000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3440000	USD
CY2021Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2974000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	193000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	210000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	402000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	418000	USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5801000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5801000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5791000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5791000	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	10753000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	10753000	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7131000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	19410000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7024000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1526000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1497000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	19274000	USD
CY2021Q1	us-gaap	Minority Interest MinorityInterest	4434000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	4376000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23844000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23650000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44047000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43653000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4364000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4568000	USD
CY2021Q1	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	672000	USD
CY2020Q1	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	633000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1198000	USD
CY2021Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	12000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1647000	USD
CY2021Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1060000	USD
CY2020Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	894000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	2930000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	3174000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	1434000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	1394000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1084000	USD
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1211000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	260000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	282000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	90000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-99000	USD
CY2021Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	3000	USD
CY2020Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	3000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	93000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-96000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-28000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	87000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-68000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	58000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	67000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	29000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-135000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31811000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	56000	USD
CY2020Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	326000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-68000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31473000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23650000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	107000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	87000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23844000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	87000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-68000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1231000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1676000	USD
CY2021Q1	ams	Non Cash Lease Expense NonCashLeaseExpense	74000	USD
CY2020Q1	ams	Non Cash Lease Expense NonCashLeaseExpense	67000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-16000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-28000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	107000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	56000	USD
CY2020Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	17000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	497000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-848000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-551000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-557000	USD
CY2021Q1	ams	Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue	-1294000	USD
CY2020Q1	ams	Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue	-383000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	26000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-35000	USD
CY2021Q1	ams	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-86000	USD
CY2020Q1	ams	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-84000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2783000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3389000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1065000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	195000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1065000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-195000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	276000	USD
CY2020Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	554000	USD
CY2021Q1	ams	Repayments Of Long Term Finance Lease Obligations RepaymentsOfLongTermFinanceLeaseObligations	638000	USD
CY2020Q1	ams	Repayments Of Long Term Finance Lease Obligations RepaymentsOfLongTermFinanceLeaseObligations	912000	USD
CY2021Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	116000	USD
CY2020Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	158000	USD
CY2021Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2020Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	326000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1030000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1950000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	688000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1244000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4325000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1779000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5013000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3023000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	260000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	282000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-4000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	34000	USD
CY2021Q1	ams	Lease Reassessment Right Of Use Assets And Lease Liabilities LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities	0	USD
CY2020Q1	ams	Lease Reassessment Right Of Use Assets And Lease Liabilities LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities	67000	USD
CY2021Q1	ams	Interest Capitalized To Property And Equipment InterestCapitalizedToPropertyAndEquipment	0	USD
CY2020Q1	ams	Interest Capitalized To Property And Equipment InterestCapitalizedToPropertyAndEquipment	32000	USD
CY2021Q1	ams	Acquisition Of Equipment With Long Term Debt Financing AcquisitionOfEquipmentWithLongTermDebtFinancing	0	USD
CY2020Q1	ams	Acquisition Of Equipment With Long Term Debt Financing AcquisitionOfEquipmentWithLongTermDebtFinancing	1184000	USD
CY2021Q1	ams	Number Of Medical Centers NumberOfMedicalCenters	13	medicalCenter
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	72290000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	76157000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	41944000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	45739000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30346000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30418000	USD
CY2021Q1	ams	Number Of Debt Instruments NumberOfDebtInstruments	5	note
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	4321000	USD
CY2021Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	8281000	USD
CY2021Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	8281000	USD
CY2021Q1	ams	Number Of Financing Leases NumberOfFinancingLeases	6	lease
CY2021Q1	ams	Number Of Financing Companies NumberOfFinancingCompanies	2	financingCompany
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	812000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	812000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	261000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	353000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	248000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	870000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	58000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	812000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	29000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-135000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6254000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6126000	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	68000	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	27000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6322000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6153000	shares
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	107000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	56000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	108000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	434000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	450000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.78
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y5M8D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	27000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	450000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.78
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y2M12D
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	425000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.79
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	417000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.79
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y7M9D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	417000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.79
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y4M9D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	19000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	407000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.80
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y3M7D
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2021Q1	ams	Short Term Debt And Finance Lease Obligations ShortTermDebtAndFinanceLeaseObligations	6669000	USD
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	782000	USD

Files In Submission

Name	View Source	Status
0000744825-21-000054-index-headers.html	Edgar Link	pending
0000744825-21-000054-index.html	Edgar Link	pending
0000744825-21-000054.txt	Edgar Link	pending
0000744825-21-000054-xbrl.zip	Edgar Link	pending
ams-20210331.htm	Edgar Link	pending
ams-20210331.xsd	Edgar Link	pending
ams-20210331_cal.xml	Edgar Link	unprocessable
ams-20210331_def.xml	Edgar Link	unprocessable
ams-20210331_htm.xml	Edgar Link	completed
ams-20210331_lab.xml	Edgar Link	unprocessable
ams-20210331_pre.xml	Edgar Link	unprocessable
ams03-31x2021ex101amendmen.htm	Edgar Link	pending
ams03-31x2021ex102amendmen.htm	Edgar Link	pending
ams03-31x2021xex312.htm	Edgar Link	pending
ams03-31x2021xex321.htm	Edgar Link	pending
ams03-31x2021xexx311.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams

2021 Q1 Form 10-Q Financial Statement

#000074482521000054 Filed on May 13, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMS AMERICAN SHARED HOSPITAL SERVICES Stock $ams

2021 Q1 Form 10-Q Financial Statement

#000074482521000054 Filed on May 13, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams